OPTIJECT 300 mg d'I/ml, solution for injection or infusion syringe, 125 ml, CIP 3400930187869
Active ingredients: Iodine, Ioversol
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection or infusionsyringe, 125 ml, CIP 3400930187869intraartérielle;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- OPTIJECT 300 mg d'I/mL, solution injectable ou pour perfusion
- Pharmaceutical form
- solution injectable ou pour perfusion
- Route of administration
- intraartérielle;intraveineuse
- Presentation description
- 1 seringue(s) préremplie(s) polypropylène de 125 ml pour injecteur automatique avec nécessaire d'administration pour injecteur Optivantage (1 prolongateur + 1 cathéter sécurisé 20G)
- Marketing authorisation holder
- GUERBET
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Jun 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67470459CIP73018786CIP133400930187869Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| IODEsolution | 300 mg · 1 mL | FT |
| IOVERSOLsolution | 636 mg · 1 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.